Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
MYI

MYI

MYI Diagnostics is a biomedical research company that focuses on multiplexed proteomic profiling for medicine.

All edits

Edits on 2 Sep, 2022
Seotaek Lee
Seotaek Lee edited on 2 Sep, 2022
Edits made to:
Infobox (+2/-1 properties)
Infobox
Company Operating Status
Active
Company Operating Status
Closed
Edits on 22 May, 2022
Ольга Дрокина"Edit from table cell"
Ольга Дрокина edited on 22 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 17 May, 2022
Katrina-Kay Pettitt"prospector:1525:725148"
Katrina-Kay Pettitt edited on 17 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 6 Jul, 2021
Golden AI"Infobox creation from: Wikidata data enrichment"
Golden AI approved a suggestion from Golden's AI on 6 Jul, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Country
Aime Anne Nisay"Approved suggestion #1084389"
Aime Anne Nisay approved a suggestion from Golden's AI on 6 Jul, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata ID
Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 5 May, 2021
Nureni Akanji
Nureni Akanji edited on 5 May, 2021
Edits made to:
Article (+1053 characters)
Article

MYi Diagnostics is a biomedical company that has expertise in multiplexed proteomic profiling for precision medicine. MYI Diagnostics performs research in order to substitute many targeted diagnostics for individual cancers, infectious diseases, metabolic conditions, and other rare disorders or conditions.

MYi Diagnostics develops a single-cell quantification technology that is intended to treat cancer. The company develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells, enabling healthcare providers to generate actionable information to streamline clinical intervention strategies.

The company is leveraging DNA technologies for high-throughput quantification of multitude of proteins in a single sample, with sensitivity down to a single cell.

...

MYi developed a technology to analyze multiple molecules in a drop of blood using a modular platform. The company aims to facilitate academic research and reduce costs of routine blood tests in the clinic.

Edits on 24 Apr, 2021
Golden AI"Graham import: Spending data"
Golden AI edited on 24 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
DUNS Number
217407935
Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Edits on 3 Aug, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 3 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Aug, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 2 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
250,000
Golden AI
Golden AI edited on 2 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 23 Feb, 2020
Golden AI"Adding location topic from lookup San Francisco, CA"
Golden AI edited on 23 Feb, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 21 Jan, 2020
Golden AI
Golden AI edited on 21 Jan, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Edits on 30 May, 2019
Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2019
Golden AI
Golden AI edited on 29 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 23 May, 2019
Golden AI
Golden AI edited on 23 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Location
Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Accelerator
Golden logo
By using this site, you agree to our Terms & Conditions.